JPMorgan Chase Boosts Stake in SI-BONE as Analyst Optimism Grows JPMorgan Chase has acquired over 100,000 shares of SI-BONE, Inc., reflecting growing institutional confidence. The move follows a series of analyst upgrades, with consensus price targets averaging $24.40. SI-BONE’s stock has recently traded higher, and analysts maintain a strong buy outlook for the medical device company.12